Literature DB >> 15793505

Adult-onset atopic dermatitis.

Esen Ozkaya1.   

Abstract

Adult-onset atopic dermatitis (AD) is a recently introduced subgroup of AD. Apart from the most typical flexural lichenified/exudative pattern in adults, patients may also have nontypical morphology and localization. The aim of this retrospective study was to find the frequency of nontypical morphology and localization in adult-onset AD and to evaluate the accuracy of United Kingdom Working Party's criteria in detecting those cases. Among 376 patients consecutively diagnosed with AD according to criteria of a previous study, 63 patients (34 women and 29 men) (16.8%) with onset of AD after the age of 18 years were allocated to the adult-onset group. A total of 7 patients (11.1%) had nonflexural involvement with nummular (6.3%), prurigo-like (3.2%), or follicular (1.6%) patterns that could not be attributed to contact sensitivities. A total of 14 patients (22.2%) did not fulfill the United Kingdom Working Party's criteria. It was interesting that United Kingdom Working Party's criteria did not cover the same patients as did the previous study's criteria in nearly one fourth of the cases.

Entities:  

Mesh:

Year:  2005        PMID: 15793505     DOI: 10.1016/j.jaad.2004.11.037

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  20 in total

1.  Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis.

Authors:  James Q Del Rosso; Sanjay Bhambri
Journal:  J Clin Aesthet Dermatol       Date:  2009-09

2.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

3.  Phenotypical Differences of Childhood- and Adult-Onset Atopic Dermatitis.

Authors:  Jonathan I Silverberg; Paras P Vakharia; Rishi Chopra; Ryan Sacotte; Neha Patel; Supriya Immaneni; Takeisha White; Robert Kantor; Derek Y Hsu
Journal:  J Allergy Clin Immunol Pract       Date:  2017-11-10

4.  Lifetime exposure to cigarette smoking and the development of adult-onset atopic dermatitis.

Authors:  C H Lee; H Y Chuang; C H Hong; S K Huang; Y C Chang; Y C Ko; H S Yu
Journal:  Br J Dermatol       Date:  2011-01-28       Impact factor: 9.302

Review 5.  The Role of Moisturizers in Addressing Various Kinds of Dermatitis: A Review.

Authors:  Schandra Purnamawati; Niken Indrastuti; Retno Danarti; Tatan Saefudin
Journal:  Clin Med Res       Date:  2017-12-11

6.  Atopic dermatitis in adults: A cross-sectional study in the department of dermatology, Antananarivo, Madagascar.

Authors:  Fandresena Arilala Sendrasoa; Samson Léophonte Ramily; Tsiory Iarintsoa Razafimaharo; Irina Mamisoa Ranaivo; Malalaniaina Andrianarison; Onivola Raharolahy; Volatantely Ratovonjanahary; Naina Harinjara Razanakoto; Mendrika Fifaliana Rakotoarisaona; Noroiarisoa Andriamanantena; Lala Soavina Ramarozatovo; Rapelanoro Rabenja Fahafahantsoa
Journal:  JAAD Int       Date:  2021-06-01

Review 7.  Chronic pruritus in the elderly: pathophysiology, diagnosis and management.

Authors:  Rodrigo Valdes-Rodriguez; Carolyn Stull; Gil Yosipovitch
Journal:  Drugs Aging       Date:  2015-03       Impact factor: 4.271

8.  Clinical features of the extrinsic and intrinsic types of adult-onset atopic dermatitis.

Authors:  Kanokvalai Kulthanan; Kanonrat Boochangkool; Papapit Tuchinda; Leena Chularojanamontri
Journal:  Asia Pac Allergy       Date:  2011-07-28

9.  Nummular eczema.

Authors:  Resham Raj Poudel; Bipin Belbase; Nisha Kusum Kafle
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-06-15

10.  Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis.

Authors:  M J Visser; L Landeck; L E Campbell; W H I McLean; S Weidinger; F Calkoen; S M John; S Kezic
Journal:  Br J Dermatol       Date:  2013-02       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.